Cyprus Mail
EuropeWorld

EU regulator endorses use of Moderna’s Covid-19 vaccine in teens

students receive covid 19 vaccines at the university of memphis
EMA's safety committee said while common side effects in teenagers after vaccination were similar to those seen in older population, due to a smaller study size, the trial could not detect new uncommon side effects or estimate the risk of known ones such as myocarditis and pericarditis

Europe’s medicines regulator on Friday recommended approving the use of Moderna’s COVID-19 vaccine in 12- to 17-year olds, paving the way for it to become the second shot okayed for adolescent use in the bloc.

The use of the vaccine, branded Spikevax, will be the same in adolescents as in people above 18 years, the European Medicines Agency (EMA) said, adding the vaccine produced a comparable antibody response to that seen in 18- to 25-year olds.

Vaccinating children has been considered important for reaching herd immunity against the novel coronavirus and in the light of the highly contagious Delta variant. Moderna in May said its vaccine was found to be safe and effective in teens.

EMA’s safety committee said while common side effects in teenagers after vaccination were similar to those seen in older population, due to a smaller study size, the trial could not detect new uncommon side effects or estimate the risk of known ones such as myocarditis and pericarditis.

Related Posts

Ukrainian heavy artillery inflicts ‘hell’ on Russian lines near Bakhmut

Reuters News Service

Pope Francis moved as Reuters photographer shows him child migrant picture

Reuters News Service

Lebanese army says it exchanged tear gas, smoke bomb fire with Israel

Reuters News Service

NASA’s first asteroid sample on track for Sunday parachute landing in Utah

Reuters News Service

Landslide causes large chunk of Swedish motorway to collapse

Reuters News Service

Russia says Karabakh Armenian fighters start giving up arms

Reuters News Service